RESUMEN
BACKGROUND: The implantable cardioverter defibrillator (ICD) is effective in preventing sudden cardiac death. However, in elderly patients (aged 75 years or older) the role of ICDs is still not well-defined and controversial. METHODS: We retrospectively analysed all clinical and survival data of all ICD patients who were ≥75 years at the date of implantation in the Erasmus MC, Rotterdam, the Netherlands and the University Hospital, Basel, Switzerland. Kaplan-Meier survival analysis was performed, and mortality predictors were identified. Mortality of the cohort was compared with a random sample of patients aged 60-70 years originating from the same database and to an age- and sex-matched cohort of Dutch persons. RESULTS: The study cohort consisted of 179 patients aged 75 years or older who were implanted between February 1999 and July 2008. The median follow-up time was 2.0 (IQR 2.8) years. Survival rates after 1, 2 and 3 years were 87, 82, 75 %, respectively. Survival was similar for primary and secondary prevention. Mortality in this study population could be predicted by combining four clinical risk factors: QRS duration >120 ms, NYHA class > II, renal failure and atrial fibrillation (AF). Survival was worse compared with the group of ICD patients aged 60-70 years and to the age- and sex-matched group of elderly persons. However, survival was not significantly worse when comparing elderly ICD patients without additional risk factors to the general population. CONCLUSIONS: Elderly patients still have an acceptable survival probability independent of prevention indication, certainly if there are no additional clinical risk factors. The presence or absence of additional clinical risk factors should be taken into account when making the decision for implantation, since they strongly correlate with survival.
RESUMEN
We present a coincidental finding of quadricuspid pulmonary valve and left pulmonary artery aneurysm. As both the pulmonary valve and the pulmonary trunk with its main branches are hard to visualise with cardiac ultrasound, most abnormalities described so far are from autopsy series. With the increasing use of CMR and its excellent potential for visualising both pulmonary valve and pulmonary arteries, we believe more cases will be discovered in the near future. Although pulmonary artery aneurysm are rare, timely detection may prevent lethal bleeding.
RESUMEN
The effect of thrombolysis in acute myocardial infarction on infarct size, left ventricular function, clinical course and patient survival was studied in a randomized trial comparing thrombolysis (269 patients) with conventional treatment (264 control patients). All 533 patients were admitted to the coronary care unit within 4 hours after the onset of symptoms related to the infarction. Baseline characteristics were similar in both groups. Informed consent was requested only of patients allocated to thrombolysis; no angiography was performed in 35. The infarct-related artery was patent in 65 patients and occluded in 169. Recanalization was achieved in 133 patients. The median time to angiographic documentation of vessel patency was 200 minutes after the onset of symptoms. The clinical course in the coronary care unit was more favorable after thrombolysis. Infarct size, estimated from myocardial enzyme release, was 30% lower after thrombolysis. In patients admitted within 1 hour after the onset of symptoms the reduction of infarct size was 51%, in those admitted between 1 and 2 hours it was 31% and in those admitted later than 2 hours it was 13%. Left ventricular function measured by radionuclide angiography before hospital discharge was better after thrombolysis (ejection fraction 48 +/- 15%) than in control patients (44 +/- 15%). Similar improvement was observed in patients with a first infarct only (thrombolysis 50 +/- 14%, control subjects 46 +/- 15%), in patients with anterior infarction (thrombolysis 44 +/- 16%, control subjects 35 +/- 14%) and in those with inferior infarction (thrombolysis 52 +/- 12%, control subjects 49 +/- 12%). Similar results were obtained by contrast angiography. Mortality was lower after thrombolysis. After 28 days 16 patients allocated to thrombolysis and 31 control patients had died. One year survival rates were 91 and 84%, respectively. On the other hand, nonfatal reinfarction occurred more frequently after thrombolysis (36 patients) than in control subjects (16 patients). Early thrombolysis by intracoronary streptokinase leads to a smaller infarct size estimated by enzyme release, preserves left ventricular function at the second week and leads to improved 1 year survival.
Asunto(s)
Infarto del Miocardio/terapia , Estreptoquinasa/uso terapéutico , Anciano , Angioplastia de Balón , Ensayos Clínicos como Asunto , Vasos Coronarios/diagnóstico por imagen , Femenino , Humanos , Hidroxibutirato Deshidrogenasa/sangre , Infusiones Intraarteriales , L-Lactato Deshidrogenasa/sangre , Masculino , Persona de Mediana Edad , Infarto del Miocardio/mortalidad , Infarto del Miocardio/fisiopatología , Cintigrafía , Distribución Aleatoria , Estreptoquinasa/administración & dosificación , Volumen SistólicoRESUMEN
Three hundred and two patients with acute myocardial infarction were enrolled in a randomized multicenter trial to compare conventional treatment with attempted recanalization by intracoronary streptokinase. In a subgroup of patients, the effects of thrombolysis on left ventricular function were evaluated within 48 hr, at 2 wk, and at 3 mo after admission. Global left ventricular ejection fraction (LVEF) was obtained by radionuclide angiography and analyzed with an automatic detection program. Paired data were determined in 160 patients (control 78, thrombolysis 82) within 48 hr and at 2 wk, and in 143 patients (control 71, thrombolysis 72) at 48 hr, 2 wk, and 3 mo. It was shown that LVEF significantly improved in the thrombolysis group as compared with controls both at 2 wk (delta LVEF thrombolysis 3.9 +/- 7.9%, p less than 0.001 compared with delta LVEF control 0.6 +/- 9.7%, p = N.S.) and at 3 mo (delta LVEF thrombolysis 3.1 +/- 12.4%, p less than 0.05 compared with delta LVEF control 2.1 +/- 12.2%, p = N.S.). When patients were divided according to infarct site, however, significant improvement at 3 mo was only observed in the patients with anterior infarction (delta LVEF thrombolysis 5.5 +/- 13.1%, p less than 0.05 compared with delta LVEF control 3.3 +/- 10.4%, p = N.S.). It was shown that acute intervention with intracoronary streptokinase has a potentially favorable and lasting effect on left ventricular function in patients with anterior myocardial infarction. This improvement might be related to the rather rapid administration of thrombolytic therapy with a median time of approximately 4 hr after onset of symptoms.
Asunto(s)
Vasos Coronarios/diagnóstico por imagen , Infarto del Miocardio/diagnóstico por imagen , Estreptoquinasa/uso terapéutico , Volumen Sistólico , Adulto , Anciano , Ensayos Clínicos como Asunto , Femenino , Ventrículos Cardíacos/efectos de los fármacos , Humanos , Masculino , Persona de Mediana Edad , Cintigrafía , Distribución Aleatoria , Estreptoquinasa/administración & dosificación , Factores de TiempoRESUMEN
Transesophageal atrial stimulation (TRAS) was combined with 2-dimensional echocardiography in 69 consecutive patients on days 3 to 5 (mean 3.3) of their first, uncomplicated myocardial infarction, to determine if inducible remote asynergy (i.e., not directly adjacent to the infarcted area and supposedly related to another vascular territory) provides information regarding (1) extent of coronary artery disease, and (2) future ischemic events. Uncomplicated, adequate stress studies were performed in 59 of 69 patients (86%); all these patients had regional asynergy at rest. Remote asynergy at rest was present in 7 patients and during TRAS in 26 patients. Coronary angiography was performed within 2 to 3 weeks after the acute phase. Multivessel disease was present in 23 of these patients and absent in 3. Of the 33 patients without remote asynergy during TRAS, 5 had multivessel disease. Sensitivity of remote asynergy during TRAS for detecting multivessel CAD was 82%, specificity 90%, and predictive accuracy 86%. New ischemic events, defined as recurrent infarction, cardiac death, or revascularization within 12 to 18 months (mean 12.6) occurred in 24 patients (41%); remote asynergy during TRAS was present in 16 of these patients (67%). It is concluded that TRAS combined with 2-dimensional echocardiography can safely be performed in the early days of acute myocardial infarction; remote asynergy during TRAS reliably identifies patients with multivessel disease and future ischemic events.
Asunto(s)
Estimulación Cardíaca Artificial , Ecocardiografía , Infarto del Miocardio/diagnóstico , Adulto , Anciano , Angiografía Coronaria , Femenino , Humanos , Masculino , Persona de Mediana Edad , Contracción Miocárdica , Infarto del Miocardio/diagnóstico por imagen , Infarto del Miocardio/fisiopatología , Valor Predictivo de las Pruebas , Pronóstico , Estudios Prospectivos , Sensibilidad y Especificidad , Factores de TiempoRESUMEN
To assess the prevalence and clinical relevance of right ventricular involvement in acute inferior wall infarction, 78 consecutive patients with the latter condition were studied with thallium-201 and technethium-99m pyrophosphate myocardial imaging. Right ventricular involvement was determined from superimposition of the 45 degree left anterior oblique thallium-201 and technetium-99m pyrophosphate images. All 78 patients shoed thallium-201 defects. Sixty-four patients had positive pyrophosphate scans, and 24 of these (37.5 percent) showed right ventricular involvement. None of the patients with right ventricular involvement in this consecutive series showed the classic signs of severe right ventricular failure, although subclinicalright ventricular dysfunction may have been present. There was no significant difference in the incidence of cardiogenic shock between the groups with and without right ventricular involvement. It is concluded that right ventricular involvement in acute inferior wall infarction is relatively frequent but not necessarily associated with severe right-sided pump failure. In patients with acute inferior wall infarction and severe pump failure, dual imaging provides a simple nonivasive method of identifying the subgroup of patients with right ventricular involvement who may benefit from volume loading.
Asunto(s)
Ventrículos Cardíacos/diagnóstico por imagen , Infarto del Miocardio/diagnóstico por imagen , Radioisótopos , Tecnecio , Talio , Adulto , Anciano , Difosfatos , Estudios de Evaluación como Asunto , Femenino , Ventrículos Cardíacos/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/fisiopatología , CintigrafíaRESUMEN
To determine the clinical significance of regional hyperkinesia and remote asynergy of noninfarcted areas in patients with a first acute myocardial infarction (AMI), 2-dimensional echocardiography was performed in 113 consecutive patients within 12 hours after admission to the coronary care unit. In 98 patients (87%) all segments of the left ventricular wall were recorded. Infarct-associated asynergy was anterior in 63 and inferior in 35 patients. Regional hyperkinesia was present in 66 patients (67%)--44 of 63 with anterior (69%) and 22 of 35 with inferior (63%) infarcts--and was more frequently seen in patients with 1- and 2-vessel coronary artery disease (CAD) than in patients with 3-vessel CAD (87 and 72% vs 25%, p less than 0.001). In contrast to enzymatic infarct size, absence of regional hyperkinesia was significantly associated with a higher left ventricular wall motion score (p less than 0.01). Twenty patients died within 30 days after onset of AMI; in 15 (75%) regional hyperkinesia was absent. Absence of regional hyperkinesia, especially in anterior infarcts, was associated with a high mortality rate (13 of 19 patients [68%]). Remote asynergy, i.e., not adjacent to the infarct area and supposed to be related to another vascular region, was present in 17 of 98 patients (17%)--11 of 63 with anterior (17%) and 6 of 35 with inferior (17%) infarcts. Remote asynergy was present only in patients with multivessel CAD and was significantly related to a higher wall motion score (p less than 0.001), but not to enzymatic infarct size.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Contracción Miocárdica , Infarto del Miocardio/fisiopatología , Adulto , Anciano , Pruebas Enzimáticas Clínicas , Angiografía Coronaria , Vasos Coronarios/patología , Creatina Quinasa/sangre , Ecocardiografía , Femenino , Humanos , Isoenzimas , Masculino , Persona de Mediana Edad , Infarto del Miocardio/diagnóstico , Infarto del Miocardio/diagnóstico por imagen , Infarto del Miocardio/patología , Miocardio/patologíaRESUMEN
To determine the clinical significance of transient remote asynergy after the first acute myocardial infarction (AMI), 2-dimensional echocardiography was performed at rest and directly after dynamic exercise in 49 consecutive patients within 3 weeks of AMI. In 43 patients (88%), technically adequate 2-dimensional echocardiographic examinations were obtained. Asynergy was found in all patients at rest. Immediately after exercise, new areas of asynergy, not adjacent to the infarcted area (i.e., transient remote asynergy), were present in 18 patients. Of these patients, 17 had multivessel coronary artery disease (CAD), compared with 5 of 25 patients without transient remote asynergy. Sensitivity of transient remote asynergy for detecting multivessel CAD was 77% and specificity was 95%. Left ventricular ejection fraction at rest and after exercise was measured in 39 patients (90%) and could only identify patients with 3-vessel CAD. New ischemic events, defined as reinfarction or recurrent angina pectoris, within a mean of 12 weeks (range 8 to 16) after discharge, occurred in 16 patients. Transient remote asynergy was present in 12 of these patients (75%). It is concluded that exercise-induced transient remote asynergy early after AMI can identify patients with multivessel CAD and a subgroup of patients prone to early new ischemic events. Left ventricular ejection fraction, however, is not only more laborious but also of lesser value in identifying patients with multivessel CAD.
Asunto(s)
Ecocardiografía , Prueba de Esfuerzo , Infarto del Miocardio/fisiopatología , Adulto , Anciano , Angina de Pecho/complicaciones , Ecocardiografía/métodos , Electrocardiografía , Estudios de Evaluación como Asunto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Recurrencia , Volumen Sistólico , Factores de TiempoRESUMEN
BACKGROUND: Cardiovascular disease is the leading cause of mortality in westernized countries. Learning more about the cause of coronary heart disease (CHD) is an essential step in the search for effective CHD prevention, both at the individual and population levels. Prospective cohort studies are particularly well suited to the study of risk markers. However, the high cost of mounting such studies, along with the newer hypotheses generated during the period of follow-up necessitates the use of plasma and serum banks for analyses of many biological parameters. METHODS: The prospective, cohort PRIME Study has recruited 10,592 men, aged 50-59 years in France and Northern Ireland, to establish new risk markers for CHD. A plasma serum bank was established comprising 240,000 samples, either in straws or tubes, which have been stored in liquid nitrogen for over 5 years. The use of straws was required to store the largest number of aliquots in the smallest possible space. Storage validation was carried out for a number of key parameters. The validity of freezing of plasma in straws was established for a number of key measurements under investigation. Simultaneously, a DNA bank was set up to facilitate genetic analyses. In contrast to the DNA bank, which enables the performance of a very large number of analyses on a small amount of material, the plasma/serum bank has to be managed very frugally, requiring laboratories to use the smallest volume possible in each analysis. RESULTS AND CONCLUSION: Problems and difficulties solved during building and use of biological banks are presented. The initial results obtained using this plasma bank have demonstrated its validity.
Asunto(s)
Bancos de Sangre/organización & administración , Recolección de Muestras de Sangre/métodos , Estudios de Cohortes , Estudios Prospectivos , Conservación de la Sangre , Enfermedades Cardiovasculares/sangre , Enfermedades Cardiovasculares/epidemiología , Criopreservación , Francia/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Irlanda del Norte/epidemiología , Factores de RiesgoRESUMEN
Pneumothorax is a mild complication during pacemaker lead implantation using the subclavian puncture technique. We report on five-year experience in 433 pacemaker lead implantation procedures in 379 patients. The cephalic vein route was solely used in twelve patients. Three procedures were performed over time in four patients and one patient needed four repetitive punctures for pacemaker lead implantation and replacement. Thus 421 punctures were carried out in 367 patients. Eleven case of pneumothorax were observed: in eight patients (1.9%) a partial pneumothorax occurred and in three patients (0.7%) the pneumothorax was nearly complete. In the latter patients a chest tube was inserted and hospital admission was prolonged for 3, 6 and 6 days, respectively. Old age with a corresponding abnormality in the form of chest deformation were predominantly found in the patients with this type of complication.
Asunto(s)
Duodeno/anomalías , Intestino Delgado/anomalías , Mesenterio/anomalías , Colostomía , Obstrucción Duodenal/diagnóstico por imagen , Femenino , Humanos , Lactante , Recién Nacido , Obstrucción Intestinal/diagnóstico por imagen , Intestino Delgado/embriología , Intestino Delgado/cirugía , Laparotomía , Masculino , RadiografíaAsunto(s)
Hiperlipoproteinemia Tipo II/cirugía , Íleon/cirugía , Tendón Calcáneo , Adulto , Colesterol/sangre , Enfermedad Coronaria/etiología , Diarrea/etiología , Femenino , Mano , Humanos , Masculino , Persona de Mediana Edad , Enfermedades Musculares/etiología , Complicaciones Posoperatorias , Tendones , Xantomatosis/etiologíaAsunto(s)
Desfibriladores Implantables , Taquicardia Ventricular/fisiopatología , Taquicardia Ventricular/terapia , Fibrilación Ventricular/fisiopatología , Fibrilación Ventricular/terapia , Adolescente , Adulto , Arritmias Cardíacas/diagnóstico , Arritmias Cardíacas/fisiopatología , Arritmias Cardíacas/terapia , Desfibriladores Implantables/estadística & datos numéricos , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Taquicardia Ventricular/diagnóstico , Fibrilación Ventricular/diagnósticoRESUMEN
Implantable cardioverter defibrillators (ICDs) with the integrated Home Monitoring feature use dedicated mobile phone and internet links to provide the physicians and technicians in the ICD clinic with the essential device- and arrhythmia-related data stored in the ICD diagnostic memory. Various counters, graphs and intracardiac electrograms are automatically transmitted via Home Monitoring each day to allow prompt, remote presentation of arrhythmias or detection of technical problems. One of the most inconvenient side-effects of the ICD therapy is inappropriate intervention of the device. Home Monitoring data can help the physician to identify and subsequently reduce the incidence of inappropriate ICD therapy.
Asunto(s)
Desfibriladores Implantables , Electrocardiografía Ambulatoria , Arritmias Cardíacas/epidemiología , Arritmias Cardíacas/terapia , Desfibriladores Implantables/efectos adversos , Falla de Equipo , Humanos , Incidencia , Aceptación de la Atención de Salud , Prevención Secundaria , TelemetríaRESUMEN
The first results of a new, single lead DDD pacing system consisting of two bipolar combinations of floating atrial ring electrodes, with the proximal ring at the vena cava superior junction, and which can be used separately for atrial sensing and pacing (VECATS) are reported. Uncomplicated implantation of the pacing system was performed in 78 patients with VDD indications. Pacing and sensing parameters were measured at implantation, before discharge (days 1-3), at 1 and 3 months in various positions and during activity. Atrial pacing threshold (AT) and diaphragmatic stimulation threshold (DT) were 3.3 +/- 1.1 V and 7.2 +/- 2.2 at implant, and 4.3 +/- 0.5 and 7.9 +/- 1.1 V at 3 months, respectively, in the European group. In the Canadian group AT increased and DT decreased during follow-up, leaving a safety margin of 1 V. Reliable intraoperative atrial pacing was possible in 93% of patients. Failures were caused by no capture (3%) or AT > DT (4%). At 3 months, 54% of the atria were consistently paced. Atrial pacing failures were due to no atrial capture (8%), and AT > DT (38%). We conclude that atrial pacing was safe and initially possible in the majority of patients with the VECATS pacing system, though diaphragmatic stimulation became more prevalent over time, due to an increase in AT threshold and a decrease in DT.
Asunto(s)
Electrodos Implantados/normas , Atrios Cardíacos/fisiopatología , Bloqueo Cardíaco/terapia , Marcapaso Artificial , Vena Cava Superior/fisiopatología , Anciano , Canadá , Diafragma/fisiopatología , Electrodos Implantados/efectos adversos , Seguridad de Equipos , Europa (Continente) , Femenino , Estudios de Seguimiento , Bloqueo Cardíaco/fisiopatología , Ventrículos Cardíacos/fisiopatología , Ventrículos Cardíacos/cirugía , Humanos , Masculino , Marcapaso Artificial/efectos adversos , Sensibilidad y Especificidad , Umbral Sensorial , Resultado del TratamientoRESUMEN
Although high-risk patients following myocardial infarct are usually identified in the acute stage by clinical assessment and determination of left ventricular function at rest, a significant percentage of infarct patients with increased risks, i.e., presence of residual myocardial ischemia, remain undetected at discharge. Since the yield of adequate images for interpretation stress echocardiograms has been significantly improved with digital technology, stress echocardiography has become a truly practical technique to identify these patients. Presence of remote asynergy, i.e., asynergy not directly adjacent to the infarcted area and supposed to be related to another vascular region, directly following cessation of dynamic exercise appears to be highly related to multivessel disease and an unfavorable follow-up period. Treadmill electrocardiographic findings, however, appeared to be of limited value in this respect. Furthermore, the echocardiographic ejection fraction was also a poor predictor. The versatility of the technique, lack of injections, or radiation hazard, and the relatively low cost will undoubtedly increase the application of stress echocardiography for postinfarct stratification.
Asunto(s)
Enfermedad Coronaria/diagnóstico por imagen , Ecocardiografía/métodos , Prueba de Esfuerzo/métodos , Infarto del Miocardio/fisiopatología , Estimulación Cardíaca Artificial , Estudios de Evaluación como Asunto , Humanos , Pronóstico , Estudios Prospectivos , Factores de Riesgo , Sensibilidad y Especificidad , Función Ventricular Izquierda/fisiologíaRESUMEN
In cases where the loss of a small volume of blood is critical to the patient's welfare, the technique of re-wiring intra-arterial and intravenous catheters that minimize the amount of blood lost is important. A simple technique is described using the needleless systems which are now widely employed throughout hospitals.
Asunto(s)
Cateterismo Periférico/métodos , Arteria Femoral , Angiografía/instrumentación , Angiografía/métodos , Cateterismo Periférico/instrumentación , Catéteres de Permanencia , Preescolar , Diseño de Equipo , Femenino , Hemorragia/prevención & control , Técnicas Hemostáticas/instrumentación , Humanos , Hígado/diagnóstico por imagen , Hígado/lesiones , Goma , Propiedades de Superficie , Trombosis/prevención & controlRESUMEN
A balloon catheter with six electrodes has been developed for transesophageal atrial stimulation of the human heart. Introduction is easy and its positioning is simple with the help of six unipolar atrial electrograms. In a group of 20 healthy volunteers, stimulation and discomfort thresholds (intolerable discomfort) were measured for three levels of pulse widths (12, 16, and 20 msec) and for five electrode configurations. Stimulation thresholds were below discomfort thresholds in each case. The stimulation threshold depended on pulse width and not on electrode configuration. The discomfort threshold, however, depended on the electrode configuration and not on the pulse width. A moderate but potentially important increase of the ratio between stimulation threshold and discomfort threshold could be achieved by combining a long pulse width (20 msec) and avoiding the largest distance between the active (cathode) and the passive (anode) electrode. Transesophageal atrial stimulation promises to be a practical noninvasive tool for the termination of regular supraventricular tachycardias, basal electrophysiological studies, and controlled acceleration of the heart rate in the study of myocardial ischemia.
Asunto(s)
Estimulación Cardíaca Artificial/métodos , Cateterismo/instrumentación , Esófago , Marcapaso Artificial , Dolor/fisiopatología , Adulto , Electrocardiografía , Electrodos , Diseño de Equipo , Femenino , Atrios Cardíacos , Humanos , Masculino , Umbral SensorialRESUMEN
A rare complication is described, in three patients. The tined tip of a ventricular pacemaker electrode was entrapped in the chordae of the tricuspid valve and could not be removed by subtle manipulations in two patients. In one patient, the electrode was removed with partial rupture of the tricuspid valve. The two electrodes remained in the entrapped position and new electrodes were inserted in all three cases. No clinical sequelae were found during follow-up of at least 24 months.
Asunto(s)
Cuerdas Tendinosas , Marcapaso Artificial/efectos adversos , Válvula Tricúspide/lesiones , Anciano , Electrodos Implantados , Diseño de Equipo , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
The expanding indications for ICD therapy and the complexity of current devices will have impact on follow-up policy. The application of ICD therapy requires elaborate attention to technical aspects, arrhythmias, and the clinical course of the underlying disease. Currently, the quality of medical supervision is dependent on scheduled regular follow-up visits. A disadvantage of long intervals can be a delay in the physician's or patient's awareness of changes in the clinical status. Some patients will need more intensive follow-up while others will have the device as a stand-by and only need technical follow-up. A possibility to address this situation, is the transmission of data, already stored in the implanted device. This will guarantee continuous patient surveillance and could possibly help to avoid unnecessary follow-up visits.